92 related articles for article (PubMed ID: 16523962)
21. [Drug nephrotoxicity. A microcomputerized databank of renal involvement and responsible "nephrotox" drugs].
Hamel JD; Biour M; Cheymol G
Therapie; 1988 May; 43(3):211-7. PubMed ID: 3420569
[No Abstract] [Full Text] [Related]
22. The downside of a drug-crazed world.
Neilson EG
J Am Soc Nephrol; 2006 Oct; 17(10):2650-1. PubMed ID: 16959823
[No Abstract] [Full Text] [Related]
23. Drug-associated disease: cytochrome P450 interactions.
Mann HJ
Crit Care Clin; 2006 Apr; 22(2):329-45, vii. PubMed ID: 16678003
[TBL] [Abstract][Full Text] [Related]
24. [Drug-induced kidney disorders].
Keusch G
Schweiz Med Wochenschr; 1982 Mar; 112(11):384-91. PubMed ID: 7071559
[TBL] [Abstract][Full Text] [Related]
25. Cephalothin-induced acute allergic interstitial nephritis.
Durham DS; Ibels LS
Aust N Z J Med; 1981 Jun; 11(3):266-7. PubMed ID: 6945839
[No Abstract] [Full Text] [Related]
26. [Drug-induced renal diseases].
Ylitalo P
Duodecim; 1983; 99(17):1206-17. PubMed ID: 6641546
[No Abstract] [Full Text] [Related]
27. [Kidney damage caused by drugs].
Girndt J
Z Hautkr; 1986 Feb; 61(3):113-7. PubMed ID: 3953133
[TBL] [Abstract][Full Text] [Related]
28. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
Lynch T; Price A
Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
[TBL] [Abstract][Full Text] [Related]
29. Acetaminophen, valadol, and analgesic renal injury.
Med Lett Drugs Ther; 1971 Sep; 13(18):74-6. PubMed ID: 5122870
[No Abstract] [Full Text] [Related]
30. [Renal function and pharmacotherapy in children].
Jovanović O
Srp Arh Celok Lek; 1995 Jun; 123 Suppl 1():15-21. PubMed ID: 18193796
[TBL] [Abstract][Full Text] [Related]
31. [Why measure drug metabolites?].
Hendset M; Hermann M
Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1786-8. PubMed ID: 17599129
[No Abstract] [Full Text] [Related]
32. Warfarin-induced allergic interstitial nephritis and leucocytoclastic vasculitis.
Kapoor KG; Bekaii-Saab T
Intern Med J; 2008 Apr; 38(4):281-3. PubMed ID: 18380703
[TBL] [Abstract][Full Text] [Related]
33. Drug-induced renal disease.
Kincaid-Smith P
Practitioner; 1978 Jun; 220(1320):862-7. PubMed ID: 683928
[No Abstract] [Full Text] [Related]
34. Nephrotoxicity of angiotensin converting enzyme inhibition.
Donker AJ
Kidney Int Suppl; 1987 May; 20():S132-7. PubMed ID: 3037162
[No Abstract] [Full Text] [Related]
35. [Another "suspect": homeopathic agent associated with acute interstitial nephritis].
Mekle G
Dtsch Med Wochenschr; 2011 Mar; 136(12):601-2; author reply 602. PubMed ID: 21412683
[No Abstract] [Full Text] [Related]
36. How the pharmacogenetics of cytochrome P450 enzymes may affect prescribing.
Roberts RL; Begg EJ; Joyce PR; Kennedy MA
N Z Med J; 2002 Mar; 115(1150):137-40. PubMed ID: 12013308
[No Abstract] [Full Text] [Related]
37. Background incidence of serum creatinine threshold rises in a predominantly female clinical trial population without underlying renal disease.
Liu Y; Hunt C; Bains C; Weil JG
Regul Toxicol Pharmacol; 2010 Nov; 58(2):297-300. PubMed ID: 20600452
[TBL] [Abstract][Full Text] [Related]
38. [The kidney and drugs].
Raviart B
Lille Med; 1976 Oct; 21(8):692-701. PubMed ID: 1004123
[No Abstract] [Full Text] [Related]
39. [Unwanted and toxic drug effects].
Dominok GW; Terhaag B
Z Arztl Fortbild (Jena); 1984; 78(23):973-6. PubMed ID: 6528640
[No Abstract] [Full Text] [Related]
40. [Acute interstitial nephritis with oliguric renal failure following phenylbutazone medication].
Kuhlmann U; Fontana A; Briner J; Steinemann U; Siegenthaler W
Schweiz Med Wochenschr; 1978 Apr; 108(13):494-9. PubMed ID: 147510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
